Keyphrases
Tumor
79%
Lung Cancer
74%
Non-small Cell Lung Cancer (NSCLC)
59%
Cancer Types
50%
Resection
46%
Cancer Genome Atlas
43%
Surgical Resection
28%
Computed Tomography
27%
Esophageal Carcinoma
26%
Thymic Epithelial Tumors
24%
International Thymic Malignancy Interest Group (ITMIG)
23%
Positron Emission Tomography
23%
Adenovirus Vector
22%
In Cancer
21%
Lobectomy
20%
Early-stage Lung Cancer
20%
Pan-cancer
20%
Confidence Interval
18%
Adenovirus
18%
Tumor Size
17%
Complementary DNA (cDNA)
16%
Human Cancer
15%
Pan-cancer Analysis
15%
Molecular Characterization
15%
Preoperative Chemotherapy
15%
Adenocarcinoma
14%
Gross Total Resection
14%
Induction Therapy
14%
Tumor Immunity
13%
Thymoma
13%
Long-term Survival
13%
Pathological Stage
13%
Esophageal Cancer
13%
Resectable Lung Cancer
12%
Pneumonectomy
12%
Tumor Subtype
12%
Overall Survival
12%
Aneuploidy
12%
Barrett's Esophagus
12%
5-year Survival
11%
Esophageal Squamous Cell Carcinoma
11%
Hernia
11%
Thoracic Surgery
11%
Driver mutations
11%
Gene Transfer Vector
11%
Primary Tumor
11%
Induction Chemotherapy
11%
Genetic Modification
11%
Quality of Life
11%
Immune Response
11%
Medicine and Dentistry
Surgery
100%
Lung Cancer
90%
Neoplasm
85%
Non Small Cell Lung Cancer
50%
Malignant Neoplasm
47%
Disease
42%
Computer Assisted Tomography
35%
Cancer
28%
Esophagus Carcinoma
26%
Lobectomy
22%
Positron Emission Tomography
22%
Pneumonectomy
21%
Thymus Cancer
21%
The Cancer Genome Atlas
21%
Esophagectomy
19%
Recurrent Disease
16%
Cancer Types
16%
Esophagus
16%
Epithelioma
15%
Carcinoma
15%
Hiatus Hernia
14%
Quality of Life
14%
Lung
14%
Clinical Stage
13%
Esophageal Cancer
13%
Long Term Survival
12%
Overall Survival
12%
Preoperative Chemotherapy
11%
Barrett Esophagus
11%
Biopsy Technique
11%
Adenocarcinoma
10%
Metastatic Carcinoma
10%
Lung Nodule
10%
Induction Chemotherapy
10%
Thorax Surgery
10%
Surgeon
10%
Mediastinal Lymph Node
10%
Clinical Trial
10%
Proportional Hazards Model
10%
Thymic Carcinoma
9%
Primary Tumor
9%
Retroperitoneal Lymph Node Dissection
9%
Thoracic Wall
9%
Hernia
9%
Cisplatin
8%
Non-Small Cell Lung Cancer
8%
Adenovirus Vector
8%
Health Care Cost
8%
Paclitaxel
8%
Lymph Node
8%